In today's economy, signing up for digital services often requires us to agree to lengthy terms and conditions that many users likely ignore and then unknowingly sign away certain rights such as filing a lawsuit or joining a class action…
Anna Eshoo
The Public Record
Anna A. Eshoo is an American politician serving as the U.S. Representative for California's 16th congressional district since 2013. A member of the Democratic Party, she has been an advocate for various issues including healthcare, technology, and environmental protection. Eshoo has played a significant role in shaping policies related to telecommunications and has been involved in efforts to improve access to healthcare for her constituents.
We still don't know who has control, but we do know that when everyone passes the buck, nothing gets resolved.
My office regularly receives complaints about aviation noise caused by commercial flights at BNA.
There is an abysmal failure of communication and a total lack of leadership here.
I thank the chairwoman who has done so much extraordinary work in leading the Science Committee and bringing this forward. Madam Speaker, I rise with great enthusiasm in support of this legislation because it is so highly consequential for…
It is a pleasure to recognize the gentleman from Texas, Mr. Crenshaw for your 5 minutes of questions.
This is, I believe, one of the most important topics we could be discussing at our Subcommittee.
I was unable to be present during roll call vote number 397. I would like the record to reflect how I would have voted: On rollcall vote number 397, I would have voted ``yes.'' Members Recorded Pursuant to House Resolution 8, 117th…
I want all Members to know that we invited the Department of Justice, the DOJ, to testify, but they chose not to appear at today's hearing.
Over 100 civil rights groups have expressed concerns about class-wide scheduling because it expands the number of drugs subject to mandatory minimum sentences.
More than 100,000 Americans have died from drug overdoses since the COVID-19 pandemic began.
The proposal would make it easier for researchers to get permission from the Federal Government to study all Schedule I substances.





